News & Updates

Show Multimedia Only
RELIEVE-AD: Atopic dermatitis patients see rapid, sustained improvements with dupilumab

RELIEVE-AD: Atopic dermatitis patients see rapid, sustained improvements with dupilumab

17 Jun 2022 byJairia Dela Cruz

The biologic dupilumab appears to be a hit with atopic dermatitis (AD) patients treated in the real-world setting, with patients experiencing prompt improvements in multiple aspects of disease control that persisted through 1 year, as shown in the results of the RELIEVE-AD* study.

17 Jun 2022
Tradition, conditioning influence parental perceptions of GERD in Asian infants Tradition, conditioning influence parental perceptions of GERD in Asian infants

Tradition, conditioning influence parental perceptions of GERD in Asian infants

17 Jun 2022 byStephen Padilla

In the first 3 months of a newborn’s life, the prevalence of gastroesophageal reflux disease (GERD) is at its peak, but most infants outgrow it by age 1 year, according to a Singapore study, noting that those breastfed at 3 weeks have a lower likelihood of GERD.

17 Jun 2022